Latest News & Updates
Breaking News
5 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Silo Pharma's QwikAgents Joins AMD AI Developer Program To Accelerate AI Platform Development
Silo Pharma's AI subsidiary QwikAgents joins AMD's AI Developer Program to accelerate development of its AI agent platform for enterprises and individual users, with plans starting at $14/month.
Simantini Singh Deo
Celcuity Receives FDA Approval For REVTORPYK To Treat Advanced HR+/HER2- Breast Cancer
Celcuity receives FDA approval for REVTORPYK (gedatolisib) to treat HR+/HER2-negative, PIK3CA wild-type advanced or metastatic breast cancer, following progression after endocrine therapy.
Simantini Singh Deo
ORIC Pharmaceuticals Launches Global Phase 3 Trial Of Rinzimetostat For Advanced Prostate Cancer
ORIC Pharmaceuticals launches the global Phase 3 Himalayas-1 trial of rinzimetostat, combined with Bayer's darolutamide, for metastatic castration-resistant prostate cancer.
Simantini Singh Deo
Spur Therapeutics Announces Leadership Transition As CEO Michael Parini Becomes Board Chair
Spur Therapeutics announces a leadership transition as CEO Michael Parini becomes Board Chair and Dr. Henning Stennicke steps in as COO, advancing FLT201 for Gaucher disease.
Simantini Singh Deo
